Literature DB >> 9353047

Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice.

L K Bockenstedt1, E Hodzic, S Feng, K W Bourrel, A de Silva, R R Montgomery, E Fikrig, J D Radolf, S W Barthold.   

Abstract

Antibodies to the outer surface proteins (Osps) A, B, and C of the spirochete Borrelia burgdorferi can prevent infection in animal models of Lyme borreliosis. We have previously demonstrated that immune serum from mice infected with B. burgdorferi N40 can also prevent challenge infection and induce disease regression in infected mice. The antigens targeted by protective and disease-modulating antibodies are presently unknown, but they do not include Osp A or Osp B. Because Osp C antibodies are present in immune mouse serum, we investigated the ability of hyperimmune serum to recombinant Osp C (N40) to protect mice against challenge infection with N40 spirochetes. In both active and passive immunization studies, Osp C (N40) antiserum failed to protect mice from challenge infection with cultured organisms. Mice actively immunized with recombinant Osp C (N40) were susceptible to tick-borne challenge infection, and nymphal ticks remained infected after feeding on Osp C-hyperimmunized mice. In contrast, similar immunization studies performed with Osp C (PKo) antiserum prevented challenge infection of mice with a clone of PKo spirochetes pathogenic for mice. Both Osp C (N40) and Osp C (PKo) antisera showed minimal in vitro borreliacidal activity, and immunofluorescence studies localized Osp C beneath the outer membrane of both N40 and PKo spirochetes. We conclude that Osp C antibody-mediated immunity is strain specific and propose that differences in Osp C surface expression by spirochetes in vivo may account for strain-specific immunity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353047      PMCID: PMC175668          DOI: 10.1128/iai.65.11.4661-4667.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding.

Authors:  A M De Silva; E Fikrig
Journal:  Am J Trop Med Hyg       Date:  1995-10       Impact factor: 2.345

2.  Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC.

Authors:  R D Gilmore; K J Kappel; M C Dolan; T R Burkot; B J Johnson
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

3.  Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.

Authors:  T G Schwan; J Piesman; W T Golde; M C Dolan; P A Rosa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

4.  Borrelia burgdorferi genes selectively expressed in the infected host.

Authors:  K Suk; S Das; W Sun; B Jwang; S W Barthold; R A Flavell; E Fikrig
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

5.  Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.

Authors:  W S Probert; R B LeFebvre
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi.

Authors:  S W Barthold; E Fikrig; L K Bockenstedt; D H Persing
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

7.  A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection.

Authors:  C I Champion; D R Blanco; J T Skare; D A Haake; M Giladi; D Foley; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

8.  Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway.

Authors:  Y Ma; K P Seiler; K F Tai; L Yang; M Woods; J J Weis
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

9.  Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.

Authors:  A M de Silva; S R Telford; L R Brunet; S W Barthold; E Fikrig
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

10.  Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease.

Authors:  R R Montgomery; S E Malawista; K J Feen; L K Bockenstedt
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  58 in total

1.  Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice.

Authors:  Emir Hodzic; Sunlian Feng; Kim J Freet; Stephen W Barthold
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

2.  Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies.

Authors:  N D Ulbrandt; D R Cassatt; N K Patel; W C Roberts; C M Bachy; C A Fazenbaker; M S Hanson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.

Authors:  Christopher G Earnhart; Richard T Marconi
Journal:  Vaccine       Date:  2007-01-17       Impact factor: 3.641

4.  Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development.

Authors:  Eric L Buckles; Christopher G Earnhart; Richard T Marconi
Journal:  Clin Vaccine Immunol       Date:  2006-10

5.  The heterogeneous motility of the Lyme disease spirochete in gelatin mimics dissemination through tissue.

Authors:  Michael W Harman; Star M Dunham-Ems; Melissa J Caimano; Alexia A Belperron; Linda K Bockenstedt; Henry C Fu; Justin D Radolf; Charles W Wolgemuth
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

6.  Specificity of infection-induced immunity among Borrelia burgdorferi sensu lato species.

Authors:  S W Barthold
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

7.  Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response.

Authors:  Christopher G Earnhart; Eric L Buckles; John Stephen Dumler; Richard T Marconi
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

8.  The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif.

Authors:  M J Mathiesen; A Holm; M Christiansen; J Blom; K Hansen; S Ostergaard; M Theisen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Maternal Antibodies Provide Bank Voles with Strain-Specific Protection against Infection by the Lyme Disease Pathogen.

Authors:  Andrea Gomez-Chamorro; Vanina Heinrich; Anouk Sarr; Owen Roethlisberger; Dolores Genné; Cindy Bregnard; Maxime Jacquet; Maarten J Voordouw
Journal:  Appl Environ Microbiol       Date:  2019-11-14       Impact factor: 4.792

Review 10.  Reviewing molecular adaptations of Lyme borreliosis spirochetes in the context of reproductive fitness in natural transmission cycles.

Authors:  Jean I Tsao
Journal:  Vet Res       Date:  2009-04-16       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.